Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China
· Delayed Price · Currency is CNY 21.00
-0.12 (-0.57%)
Feb 28, 2025, 2:45 PM CST
SHE:002262 Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.38B CNY in the quarter ending September 30, 2024, with 10.07% growth. This brings the company's revenue in the last twelve months to 5.53B, up 14.41% year-over-year. In the year 2023, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.04B with 17.28% growth.
Revenue (ttm)
5.53B
Revenue Growth
+14.41%
P/S Ratio
3.83
Revenue / Employee
1.03M
Employees
5,394
Market Cap
21.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
| Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
| Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
| Dec 31, 2020 | 3.36B | -788.01M | -18.99% |
| Dec 31, 2019 | 4.15B | 291.14M | 7.55% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.85B |